October 7, 2023 Comments Off on New patent for Viiv Hlthcare drug DOVATO Posted in: Patent Added Annual Drug Patent Expirations for DOVATO Dovato is a drug marketed by Viiv Hlthcare and is included in one NDA. It is available from one supplier. There are three patents…
The post New patent for Viiv Hlthcare drug DOVATO appeared first on DrugPatentW…
October 7, 2023 Comments Off on New tentative approval for Mylan Gmbh drug trastuzumab-dkst Posted in: Tentative Approval For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact [email protected] or visit www.DrugPatentWatch.com
The post New tentative approval for Mylan Gmbh drug trastuzumab-dkst appeared …
